Inventor · disambiguated record
Dean Welsch
Also filed as: WELSCH DEAN · WELSCH DEAN J · WELSCH DEAN JAMES
22 granted patents·9 pending applications·62 citations·filing 1994–2024
93Inventor score
Files withBIOMED VALLEY DISCOVERIES INC21IMMUNOMET THERAPEUTICS INC2THE US SECRETARY DEPARTMENT OF HEALTH2US HEALTH2PHARMACIA CORP1
Top patents by PatentIndex Score
31 records- 0196US9765142B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2014·Granted Sep 19, 2017·31 cites·49 claims
- 0293US9676746B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jun 13, 2017·6 cites·82 claims
- 0388US10604582B2Anti-CD276 antibodies (B7H3)THE US SECRETARY DEPARTMENT OF HEALTH·Filed 2015·Granted Mar 31, 2020·4 cites·37 claims
- 0487US11246859B2Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Feb 15, 2022·2 cites·3 claims
- 0587US10881646B2Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Jan 5, 2021·2 cites·12 claims
- 0686US2025084059A1CRYSTALLINE FORMS OF C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 0785US2024374604A1Cancer treatments using combinations of cdk and erk inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 0884US12076324B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2023·Granted Sep 3, 2024·0 cites·24 claims
- 0983US11007184B2Cancer treatments using combinations of type 2 MEK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 18, 2021·3 cites·33 claims
- 1083US10668055B2Cancer treatment using combinations of ERK and RAF inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Jun 2, 2020·3 cites·27 claims
- 1182US10183927B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Jan 22, 2019·2 cites·26 claims
- 1282US9951041B2Crystalline C21H22Cl2N4O2 malonateBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Apr 24, 2018·3 cites·11 claims
- 1382US9670177B2Crystalline C21H22Cl2N4O2 malonateBIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jun 6, 2017·3 cites·22 claims
- 1480US12187698B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2022·Granted Jan 7, 2025·0 cites·10 claims
- 1577US11007183B2Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 18, 2021·1 cites·22 claims
- 1676US11679112B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2021·Granted Jun 20, 2023·0 cites·50 claims
- 1773US11013743B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 25, 2021·0 cites·33 claims
- 1873US10738027B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2018·Granted Aug 11, 2020·0 cites·10 claims
- 1972US11390600B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Jul 19, 2022·0 cites·10 claims
- 2071US11135225B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Oct 5, 2021·0 cites·22 claims
- 2171US2021038587A1Methods and compositions for treating non-erk mapk pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2020·Application pending·0 cites
- 2267US11851498B2Anti-CD276 antibodies (B7H3)THE US SECRETARY DEPARTMENT OF HEALTH·Filed 2020·Granted Dec 26, 2023·0 cites·20 claims
- 2360US10196443B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2017·Granted Feb 5, 2019·0 cites·33 claims
- 2460US2025170096A1Oxphos inhibitors for use in treating cancerIMMUNOMET THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2560US2023000820A1Solid dosage form of n-1-pyrrolidine-n-5-(3-trifluoromethoxy)phenyl biguanide and uses thereofIMMUNOMET THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2653US2016317519A1Methods and compositions for treating non-erk mapk pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2016·Application pending·0 cites
- 2747US2016145355A1Bispecific antibodiesBIOMED VALLEY DISCOVERIES INC·Filed 2014·Application pending·0 cites
- 2838US7115378B2Peptide biomarker and method of identificationPHARMACIA CORP·Filed 2002·Granted Oct 3, 2006·0 cites·17 claims
- 2932US2003054426A1Peptide biomarker and method of identificationFiled 2002·Application pending·0 cites
- 3030US2003219843A1Methods of diagnosing and treating abnormal growthFiled 2002·Application pending·0 cites
- 3127US5952210ANucleic acids and expression vectors encoding human leukotiene C4 synthaseSEARLE & CO·Filed 1994·Granted Sep 14, 1999·2 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Dean Welsch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →